Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back To Search Results
Device Classification Name Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies
510(k) Number K200009
Device Name Adaptive Biotechnologies clonoSEQ Assay
Applicant
Adaptive Biotechnologies Corporation
1551 Eastlake Ave E., Ste 200
Seattle,  WA  98102
Applicant Contact Megan Duncan
Correspondent
Adaptive Biotechnologies Corporation
1551 Eastlake Ave E., Ste 200
Seattle,  WA  98102
Correspondent Contact Pamela Swatkowski
Classification Product Code
QDC  
Date Received01/02/2020
Decision Date 08/05/2020
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Pathology
510k Review Panel Molecular Genetics
Summary Summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Combination Product No
Predetermined Change
Control Plan Authorized		 No
-
-